Literature DB >> 33470389

Age-related differences in clinical characteristics of Kawasaki disease.

Yu Peng1, Xiaohui Liu1, Zhao Duan1, Sufen Cai1, Junkai Duan2, Yulan Zhou3.   

Abstract

This study aimed to examine and summarize clinical characteristics of Kawasaki disease (KD) at different ages to further strengthen clinicians understanding of children with KD, improving the level of diagnosis, and reducing coronary artery complications of KD. A total of 398 patients with KD who were diagnosed between January 2016 and December 2017 were reviewed retrospectively. These participants were allocated into three groups according to age: group A (<1 year, n=62), group B (≥1 and <5 years, n=286), and group C (≥5 years, n=50). Clinical manifestations, laboratory results, and echocardiographic findings were compared among the groups. Most (71.86%) patients with KD were aged 1-5 years. The prevalence of cervical lymphadenopathy was lowest in group A. The duration of fever before admission was longest in group A. The rate of cervical lymphadenopathy and laboratory data were different among the groups. Group A had higher frequencies of gastrointestinal involvement, neurological symptoms, and redness at the Bacillus Calmette-Guerin inoculation site than the other groups. Infants aged <1 year with KD often have a longer duration of fever before admission, a lower prevalence of cervical lymphadenopathy, and a higher prevalence of gastrointestinal and neurological symptoms.

Entities:  

Mesh:

Year:  2021        PMID: 33470389      PMCID: PMC7812906          DOI: 10.1590/1414-431X202010281

Source DB:  PubMed          Journal:  Braz J Med Biol Res        ISSN: 0100-879X            Impact factor:   2.590


  28 in total

1.  Age-related differences in the course of the acute phase symptoms of Kawasaki disease.

Authors:  Yusuke Shiozawa; Ryo Inuzuka; Yutaka Harita; Jiro Kagawa
Journal:  Pediatr Infect Dis J       Date:  2013-09       Impact factor: 2.129

2.  Guidelines for diagnosis and management of cardiovascular sequelae in Kawasaki disease (JCS 2013). Digest version.

Authors: 
Journal:  Circ J       Date:  2014-09-22       Impact factor: 2.993

Review 3.  Pyuria in patients with Kawasaki disease.

Authors:  Toru Watanabe
Journal:  World J Clin Pediatr       Date:  2015-05-08

4.  Affects of "age at diagnosis" on coronary artery lesions in patients with incomplete kawasaki disease.

Authors:  Min A Cho; Yeon Joo Choi; Jo Won Jung
Journal:  Korean Circ J       Date:  2010-06-29       Impact factor: 3.243

5.  Changes in Profiles of Kawasaki Disease Noted over Time in Suzhou, China.

Authors:  Ling Sun; Yunjia Tang; Ye Wang; Guanghui Qian; Wenhua Yan; Bo Wang; Xuan Li; Haitao Lv
Journal:  Cardiology       Date:  2018-10-10       Impact factor: 1.869

6.  Kawasaki disease patients with redness or crust formation at the Bacille Calmette-Guérin inoculation site.

Authors:  Ritei Uehara; Hiroshi Igarashi; Mayumi Yashiro; Yosikazu Nakamura; Hiroshi Yanagawa
Journal:  Pediatr Infect Dis J       Date:  2010-05       Impact factor: 2.129

Review 7.  Epidemiology of Kawasaki disease in Asia, Europe, and the United States.

Authors:  Ritei Uehara; Ermias D Belay
Journal:  J Epidemiol       Date:  2012-02-04       Impact factor: 3.211

8.  Paediatric multisystem inflammatory syndrome temporally associated with SARS-CoV-2 mimicking Kawasaki disease (Kawa-COVID-19): a multicentre cohort.

Authors:  Marie Pouletty; Charlotte Borocco; Naim Ouldali; Marion Caseris; Romain Basmaci; Noémie Lachaume; Philippe Bensaid; Samia Pichard; Hanane Kouider; Guillaume Morelle; Irina Craiu; Corinne Pondarre; Anna Deho; Arielle Maroni; Mehdi Oualha; Zahir Amoura; Julien Haroche; Juliette Chommeloux; Fanny Bajolle; Constance Beyler; Stéphane Bonacorsi; Guislaine Carcelain; Isabelle Koné-Paut; Brigitte Bader-Meunier; Albert Faye; Ulrich Meinzer; Caroline Galeotti; Isabelle Melki
Journal:  Ann Rheum Dis       Date:  2020-06-11       Impact factor: 19.103

9.  Risk Model Development and Validation for Prediction of Coronary Artery Aneurysms in Kawasaki Disease in a North American Population.

Authors:  Mary Beth F Son; Kimberlee Gauvreau; Adriana H Tremoulet; Mindy Lo; Annette L Baker; Sarah de Ferranti; Fatma Dedeoglu; Robert P Sundel; Kevin G Friedman; Jane C Burns; Jane W Newburger
Journal:  J Am Heart Assoc       Date:  2019-06-04       Impact factor: 5.501

10.  Epidemiological and clinical features of Kawasaki disease in Spain over 5 years and risk factors for aneurysm development. (2011-2016): KAWA-RACE study group.

Authors:  Elisa Fernandez-Cooke; Ana Barrios Tascón; Judith Sánchez-Manubens; Jordi Antón; Carlos Daniel Grasa Lozano; Javier Aracil Santos; Enrique Villalobos Pinto; Daniel Clemente Garulo; Beatriz Mercader Rodríguez; Matilde Bustillo Alonso; Esmeralda Nuñez Cuadros; Maria Luisa Navarro Gómez; Sara Domínguez-Rodríguez; Cristina Calvo
Journal:  PLoS One       Date:  2019-05-20       Impact factor: 3.240

View more
  1 in total

Review 1.  Clinical Manifestations and Laboratory Findings of Kawasaki Disease: Beyond the Classic Diagnostic Features.

Authors:  Wendy Lee; Chooi San Cheah; Siti Aisyah Suhaini; Abdullah Harith Azidin; Mohammad Shukri Khoo; Noor Akmal Shareela Ismail; Adli Ali
Journal:  Medicina (Kaunas)       Date:  2022-05-30       Impact factor: 2.948

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.